Kääpä Biotech secures €9 million investment led by PeakBridge to enhance production capacity and market presence in the global nutraceuticals sector.
Amount Raised
€9 Million
Round Type
Venture
KarjalohjaBiotechnologyHealth CareDietary SupplementsNutritionInvestors
Description
Kääpä Biotech, a Finnish start-up specializing in functional mushroom ingredients, has secured a €9 million strategic investment. The funding will aid in increasing production capacity, scaling operations, and meeting surging demand in the wellness industry. Led by PeakBridge and Zintinus, this investment supports Kääpä's growth plans in the global nutraceuticals market. The company aims to deliver premium, traceable, and clinically validated mushroom ingredients.
Quick answer
KÄÄPÄ Biotech raised €9 Million in a funding round, dated November 13, 2025. Investors: Peakbridge and Zintinus. KÄÄPÄ Biotech is based in Karjalohja, Uusimaa, Finland.
- How much did KÄÄPÄ Biotech raise?
- KÄÄPÄ Biotech raised €9 Million in a funding round on November 13, 2025.
- Who invested in KÄÄPÄ Biotech?
- Peakbridge and Zintinus are named as investors in this round.
- What does KÄÄPÄ Biotech do?
- KÄÄPÄ Biotech is a biotechnology company that researches, innovates and develops functional mushroom products, has three divisions: KÄÄPÄ Forest, KÄÄPÄ Mushrooms and Nordic Mushrooms.
- Where is KÄÄPÄ Biotech based and how big is it?
- KÄÄPÄ Biotech is based in Karjalohja, Uusimaa, Finland. Fundz records about 23 employees.
- Who are the decision-makers at KÄÄPÄ Biotech?
- Fundz holds 4 contacts at KÄÄPÄ Biotech, including the Chief Marketing Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Dietary Supplements and Nutrition around the same time
Companies in the same sectors as KÄÄPÄ Biotech that raised within 45 days of this round, from Fundz verified event records.
- Prime IV Hydration & Wellness raised an undisclosed amount (Debt Financing) on December 17, 2025.
- Heights raised $2.7M (Seed) on December 9, 2025.
- Naiad raised $600K (Seed) on November 26, 2025.
- Plant People raised an undisclosed amount (Series A) on November 12, 2025.
- Cymbiotika raised $25M (Seed) on November 8, 2025.
- Functional Brands raised $8M on November 5, 2025.
Who to call at KÄÄPÄ Biotech, and when
A new round usually means KÄÄPÄ Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day KÄÄPÄ Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KÄÄPÄ Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KÄÄPÄ Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KÄÄPÄ Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
KÄÄPÄ Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.